Answers are grounded in this paper and cite their sources.
Background Nutritional risk is prevalent among patients with non–small cell lung cancer (NSCLC), yet remains underrecognized in routine clinical practice and administrative datasets, with significant implications for clinical outcomes and hospital reimbursement. This study aims to evaluate the extent of malnutrition underdocumentation, its association with postoperative outcomes, and its implications within a Diagnosis-Related Group (DRG)–based reimbursement system. Methods We conducted a retrospective, single-center cohort study including 197 patients undergoing curative-intent surgery for NSCLC between 2015 and 2024. Nutritional status was assessed using body mass index (BMI), Nutritional Risk Screening 2002 (NRS), and the Graz Malnutrition Screening (GMS) tool. Discrepancies between clinically assessed nutritional risk and administrative coding of malnutrition were analyzed. Multivariable regression models were used to evaluate associations with postoperative complications and length of stay (LOS). Reimbursement was analyzed using generalized linear models with gamma distribution with log-link, and marginal effects were calculated to estimate absolute differences. Results The proportion of patients identified at nutritional risk varied substantially by assessment method: 28.4% by BMI, 33% by NRS ≥ 3, and 65% by GMS ≥ 3, where as only 11.7% of patients had malnutrition documented in administrative data. GMS-defined risk of malnutrition was independently associated with increased postoperative complications (odds ratio [OR] = 2.45, p = 0.003) and prolonged LOS (rate ratio [RR] 1.31, p < 0.001). In contrast, administratively coded malnutrition was not associated with these outcomes. Although nutritional risk was associated with higher reimbursement (+€2,210), coding itself was not an independent predictor after adjustment. Tumor stage and surgical complexity remained the primary drivers of reimbursement. Conclusion Nutritional risk in patients undergoing surgery for NSCLC is substantially underdocumented in routine hospital data, limiting its utility for clinical risk stratification and reimbursement accuracy. Nutritional risk was associated with higher reimbursement in the initial model but that this was attenuated and no longer significant after adjustment for CMI and PCCL. This indicates that the economic effect of nutritional status is mediated through DRG-related measures of clinical complexity, and the finding should be interpreted with caution. Systematic nutritional screening and standardized documentation represent feasible, high-impact interventions to improve outcome prediction, resource allocation, and transparency in DRG-based reimbursement systems. Integration of nutritional assessment into perioperative workflows should be prioritized as part of quality improvement strategies in thoracic oncology care. Clinical trial number Not applicable.
No takes yet. Share an insight, caveat, or question.
Dörr et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: